122,629 Shares in Certara, Inc. $CERT Acquired by Deutsche Bank AG

Key Points

• Deutsche Bank acquired 122,629 Certara shares during the second quarter, valued at approximately $803,000, giving it about 0.08% ownership. Institutional investors collectively own 73.96% of the company.
• Certara reported weaker-than-expected quarterly results, with EPS of $0.08 versus estimates of $0.09 and revenue of $93.27 million versus $98.09 million; revenue declined 10.8% year over year.
• Analysts have an overall “Hold” rating on Certara, with an average price target of $8.28. The stock recently opened at $8.29, while several analysts have reduced their price targets.

Deutsche Bank AG acquired a new stake in Certara, Inc. (NASDAQ:CERT - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 122,629 shares of the company's stock, valued at approximately $803,000. Deutsche Bank AG owned about 0.08% of Certara at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Northwestern Mutual Wealth Management Co. increased its holdings in shares of Certara by 2,733.3% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,975 shares of the company's stock worth $26,000 after buying an additional 2,870 shares in the last quarter. Osaic Holdings Inc. grew its position in Certara by 50.7% during the 2nd quarter. Osaic Holdings Inc. now owns 3,491 shares of the company's stock worth $41,000 after acquiring an additional 1,175 shares during the last quarter. Tower Research Capital LLC TRC increased its holdings in Certara by 499.5% in the 2nd quarter. Tower Research Capital LLC TRC now owns 5,917 shares of the company's stock worth $69,000 after purchasing an additional 4,930 shares in the last quarter. State of Wyoming acquired a new position in Certara in the 2nd quarter worth about $72,000. Finally, Pacer Advisors Inc. raised its position in Certara by 28.1% in the first quarter. Pacer Advisors Inc. now owns 13,093 shares of the company's stock valued at $75,000 after purchasing an additional 2,871 shares during the last quarter. Institutional investors and hedge funds own 73.96% of the company's stock.

Certara Price Performance

Shares of CERT opened at $8.29 on Tuesday. Certara, Inc. has a 1 year low of $4.45 and a 1 year high of $13.88. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.55 and a quick ratio of 2.55. The company has a market capitalization of $1.26 billion, a price-to-earnings ratio of -18.42 and a beta of 1.44. The business has a 50-day moving average of $7.43 and a 200-day moving average of $6.48.

Certara (NASDAQ:CERT - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.08 EPS for the quarter, missing analysts' consensus estimates of $0.09 by ($0.01). Certara had a positive return on equity of 3.86% and a negative net margin of 16.75%.The company had revenue of $93.27 million during the quarter, compared to analyst estimates of $98.09 million. During the same period in the prior year, the firm earned $0.07 earnings per share. Certara's revenue was down 10.8% compared to the same quarter last year. As a group, equities research analysts anticipate that Certara, Inc. will post 0.22 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. Craig Hallum lowered their price objective on Certara from $10.00 to $8.00 and set a "hold" rating for the company in a research note on Tuesday, May 12th. Morgan Stanley cut their target price on shares of Certara from $11.00 to $10.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 12th. Weiss Ratings raised shares of Certara from a "sell (e+)" rating to a "sell (d)" rating in a report on Wednesday, August 5th. Stephens decreased their price target on shares of Certara from $10.00 to $9.00 and set an "overweight" rating for the company in a research report on Tuesday, May 12th. Finally, BMO Capital Markets decreased their price target on shares of Certara from $7.00 to $6.00 and set a "market perform" rating for the company in a research report on Tuesday, May 12th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, Certara has an average rating of "Hold" and an average target price of $8.28.

About Certara

Certara is a biosimulation software and services company that partners with pharmaceutical, biotechnology and medical device developers to accelerate drug discovery, development and regulatory approval. The company's platform integrates quantitative pharmacology, real-world evidence, artificial intelligence and machine learning to model and simulate drug behavior across a range of therapeutic areas and patient populations. By applying these mechanistic and data-driven approaches, Certara helps its clients predict clinical outcomes, optimize dosing strategies and streamline decision-making throughout the product lifecycle.

The company's offerings are divided into software tools and consulting services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source